New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

FHS
April 5, 2024
9:57 am

The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).

CHMP recommends AbbVie’s migraine drug, GSK’s anemia treatment

The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended this week that the European Commission authorize two new treatments for migraine and chronic

June 24, 2023

Revolutionizing brain tumor treatment: the rise of AI in neuro-oncology

The current state of knowledge about the role of artificial intelligence (AI) in the diagnosis, treatment, and prognosis of brain tumors.

April 2, 2024

Scientists discover role of tumor stiffness in promoting cancer cell proliferation

In 2022 alone, over 20 million people were diagnosed with cancer, and nearly 10 million died from the disease, according to the World Health Organization.

December 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.